This grant, provided by the Department of Arthritis and Musculoskeletal and Skin Diseases, supports late-stage translation of biomedical and behavioral research. Its purpose is to transition promising findings from academic or non-profit laboratories into marketable solutions for arthritis, musculoskeletal, and skin diseases. This Small Business Innovation Research (SBIR) grant (R43/R44) funds advanced development bringing research closer to commercial viability. Crucially, clinical trials are excluded; the focus is on other essential steps in the product development pipeline. This initiative bridges the gap between discovery and practical application, ensuring impactful research reaches the public.
Opportunity ID: 344212
General Information
Document Type: | Grants Notice |
Funding Opportunity Number: | PAR-23-032 |
Funding Opportunity Title: | Late-Stage Translation of Biomedical and Behavioral Research Results in Arthritis and Musculoskeletal and Skin Diseases from Academic/Non-profit Lab to Marketplace (SBIR [R43/R44] Clinical Trial Not Allowed) |
Opportunity Category: | Discretionary |
Opportunity Category Explanation: | – |
Funding Instrument Type: | Grant |
Category of Funding Activity: | Health |
Category Explanation: | – |
Expected Number of Awards: | – |
Assistance Listings: | 93.846 — Arthritis, Musculoskeletal and Skin Diseases Research |
Cost Sharing or Matching Requirement: | No |
Version: | Synopsis 2 |
Posted Date: | Oct 27, 2022 |
Last Updated Date: | Nov 06, 2023 |
Original Closing Date for Applications: | Sep 05, 2025 |
Current Closing Date for Applications: | Sep 05, 2025 |
Archive Date: | Oct 11, 2025 |
Estimated Total Program Funding: | – |
Award Ceiling: | $350,000 |
Award Floor: | – |
Eligibility
Eligible Applicants: | Small businesses |
Additional Information on Eligibility: | Other Eligible Applicants include the following:Non-domestic (non-U.S.) Entities (Foreign Institutions) are not eligible to apply.Non-domestic (non-U.S.) components of U.S. Organizations are not eligible to apply.Foreign components, as defined in the NIH Grants Policy Statement, may be allowed. |
Additional Information
Agency Name: | National Institutes of Health |
Description: |
Late-Stage Translation of Biomedical and Behavioral Research Results in Arthritis and Musculoskeletal and Skin Diseases from Academic/Non-profit Lab to Marketplace (SBIR [R43/R44] Clinical Trial Not Allowed) |
Link to Additional Information: | https://grants.nih.gov/grants/guide/pa-files/PAR-23-032.html |
Grantor Contact Information: | If you have difficulty accessing the full announcement electronically, please contact:
NIH Grants Information
grantsinfo@nih.gov Email:grantsinfo@nih.gov |
Version History
Version | Modification Description | Updated Date |
---|---|---|
updated award ceiling | Nov 06, 2023 | |
Oct 27, 2022 |
DISPLAYING: Synopsis 2
General Information
Document Type: | Grants Notice |
Funding Opportunity Number: | PAR-23-032 |
Funding Opportunity Title: | Late-Stage Translation of Biomedical and Behavioral Research Results in Arthritis and Musculoskeletal and Skin Diseases from Academic/Non-profit Lab to Marketplace (SBIR [R43/R44] Clinical Trial Not Allowed) |
Opportunity Category: | Discretionary |
Opportunity Category Explanation: | – |
Funding Instrument Type: | Grant |
Category of Funding Activity: | Health |
Category Explanation: | – |
Expected Number of Awards: | – |
Assistance Listings: | 93.846 — Arthritis, Musculoskeletal and Skin Diseases Research |
Cost Sharing or Matching Requirement: | No |
Version: | Synopsis 2 |
Posted Date: | Oct 27, 2022 |
Last Updated Date: | Nov 06, 2023 |
Original Closing Date for Applications: | Sep 05, 2025 |
Current Closing Date for Applications: | Sep 05, 2025 |
Archive Date: | Oct 11, 2025 |
Estimated Total Program Funding: | – |
Award Ceiling: | $350,000 |
Award Floor: | – |
Eligibility
Eligible Applicants: | Small businesses |
Additional Information on Eligibility: | Other Eligible Applicants include the following:Non-domestic (non-U.S.) Entities (Foreign Institutions) are not eligible to apply.Non-domestic (non-U.S.) components of U.S. Organizations are not eligible to apply.Foreign components, as defined in the NIH Grants Policy Statement, may be allowed. |
Additional Information
Agency Name: | National Institutes of Health |
Description: |
Late-Stage Translation of Biomedical and Behavioral Research Results in Arthritis and Musculoskeletal and Skin Diseases from Academic/Non-profit Lab to Marketplace (SBIR [R43/R44] Clinical Trial Not Allowed) |
Link to Additional Information: | https://grants.nih.gov/grants/guide/pa-files/PAR-23-032.html |
Grantor Contact Information: | If you have difficulty accessing the full announcement electronically, please contact:
NIH Grants Information
grantsinfo@nih.gov Email:grantsinfo@nih.gov |
DISPLAYING: Synopsis 1
General Information
Document Type: | Grants Notice |
Funding Opportunity Number: | PAR-23-032 |
Funding Opportunity Title: | Late-Stage Translation of Biomedical and Behavioral Research Results in Arthritis and Musculoskeletal and Skin Diseases from Academic/Non-profit Lab to Marketplace (SBIR [R43/R44] Clinical Trial Not Allowed) |
Opportunity Category: | Discretionary |
Opportunity Category Explanation: | – |
Funding Instrument Type: | Grant |
Category of Funding Activity: | Health |
Category Explanation: | – |
Expected Number of Awards: | – |
Assistance Listings: | 93.846 — Arthritis, Musculoskeletal and Skin Diseases Research |
Cost Sharing or Matching Requirement: | No |
Version: | Synopsis 1 |
Posted Date: | Oct 27, 2022 |
Last Updated Date: | Oct 27, 2022 |
Original Closing Date for Applications: | – |
Current Closing Date for Applications: | Sep 05, 2025 |
Archive Date: | Oct 11, 2025 |
Estimated Total Program Funding: | – |
Award Ceiling: | $300,000 |
Award Floor: | – |
Eligibility
Eligible Applicants: | Small businesses |
Additional Information on Eligibility: | Other Eligible Applicants include the following: Non-domestic (non-U.S.) Entities (Foreign Institutions) are not eligible to apply. Non-domestic (non-U.S.) components of U.S. Organizations are not eligible to apply. Foreign components, as defined in the NIH Grants Policy Statement, may be allowed. |
Additional Information
Agency Name: | National Institutes of Health |
Description: | Late-Stage Translation of Biomedical and Behavioral Research Results in Arthritis and Musculoskeletal and Skin Diseases from Academic/Non-profit Lab to Marketplace (SBIR [R43/R44] Clinical Trial Not Allowed) |
Link to Additional Information: | https://grants.nih.gov/grants/guide/pa-files/PAR-23-032.html |
Grantor Contact Information: | If you have difficulty accessing the full announcement electronically, please contact:
NIH Grants Information
grantsinfo@nih.gov Email:grantsinfo@nih.gov |
Related Documents
Folder 344212 Full Announcement-PAR-23-032 -> PAR-23-032-Full-Announcement.pdf
Packages
Agency Contact Information: | NIH Grants Information grantsinfo@nih.gov Email: grantsinfo@nih.gov |
Who Can Apply: | Organization Applicants |
Assistance Listing Number | Competition ID | Competition Title | Opportunity Package ID | Opening Date | Closing Date | Actions |
---|---|---|---|---|---|---|
FORMS-G | Use for due dates on or before January 24, 2023 | PKG00277470 | Dec 05, 2022 | Jan 24, 2023 | View | |
FORMS-H | Use for due dates on or before January 24, 2025 | PKG00278373 | Dec 05, 2022 | Jan 24, 2025 | View | |
FORMS-I | Use for due dates on or after January 25, 2025 | PKG00289068 | Nov 26, 2024 | Sep 05, 2025 | View |
Package 1
Mandatory forms
344212 RR_SF424_5_0-5.0.pdf
344212 PHS398_CoverPageSupplement_5_0-5.0.pdf
344212 RR_OtherProjectInfo_1_4-1.4.pdf
344212 PerformanceSite_4_0-4.0.pdf
344212 RR_KeyPersonExpanded_4_0-4.0.pdf
344212 RR_Budget_3_0-3.0.pdf
344212 PHS398_ResearchPlan_5_0-5.0.pdf
344212 SBIR_STTR_Information_3_0-3.0.pdf
344212 PHSHumanSubjectsAndClinicalTrialsInfo_3_0-3.0.pdf
Optional forms
344212 RR_SubawardBudget30_3_0-3.0.pdf
344212 PHS_AssignmentRequestForm_4_0-4.0.pdf
Package 2
Mandatory forms
344212 RR_SF424_5_0-5.0.pdf
344212 PHS398_CoverPageSupplement_5_0-5.0.pdf
344212 RR_OtherProjectInfo_1_4-1.4.pdf
344212 PerformanceSite_4_0-4.0.pdf
344212 RR_KeyPersonExpanded_4_0-4.0.pdf
344212 RR_Budget_3_0-3.0.pdf
344212 PHS398_ResearchPlan_4_0-4.0.pdf
344212 SBIR_STTR_Information_3_0-3.0.pdf
344212 PHSHumanSubjectsAndClinicalTrialsInfo_3_0-3.0.pdf
Optional forms
344212 RR_SubawardBudget30_3_0-3.0.pdf
344212 PHS_AssignmentRequestForm_3_0-3.0.pdf
Package 3
Mandatory forms
344212 RR_SF424_5_0-5.0.pdf
344212 PHS398_CoverPageSupplement_5_0-5.0.pdf
344212 RR_OtherProjectInfo_1_4-1.4.pdf
344212 PerformanceSite_4_0-4.0.pdf
344212 RR_KeyPersonExpanded_4_0-4.0.pdf
344212 RR_Budget_3_0-3.0.pdf
344212 PHS398_ResearchPlan_5_0-5.0.pdf
344212 SBIR_STTR_Information_3_0-3.0.pdf
344212 PHSHumanSubjectsAndClinicalTrialsInfo_3_0-3.0.pdf
Optional forms
344212 RR_SubawardBudget30_3_0-3.0.pdf
344212 PHS_AssignmentRequestForm_3_0-3.0.pdf